Couple-Coordinated Lifestyle Intervention for Women With a History of Gestational Diabetes Mellitus

August 8, 2026 updated by: Cheng chunxia, The Third Xiangya Hospital of Central South University

Effectiveness of a Couple-Coordinated Lifestyle Intervention Among Women With a History of Gestational Diabetes Mellitus

The goal of this clinical trial is to evaluate the effects of a couple-based collaborative lifestyle intervention among women with a history of gestational diabetes. The main questions it aims to answer are:

Does the intervention improve body mass index and 2-hour plasma glucose after an oral glucose tolerance test? Does the intervention improve health behaviors, psychological well-being, self-efficacy, couple functioning, and life satisfaction?

Researchers will compare a couple-based collaborative lifestyle intervention with a woman-only lifestyle intervention to determine whether adding spousal collaboration and support leads to greater improvements.

Participants will:

Receive healthy lifestyle education posts for 3 months. In the couple-based group, also receive instant messages on behavioral promotion and couple collaboration and support videos.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

362

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hunan
      • Changde, Hunan, China, 415003
        • Changde First People's Hospital
        • Contact:
      • Changsha, Hunan, China, 410004
        • Changsha Central Hospital
        • Contact:
      • Huaihua, Hunan, China, 418000
        • General Hospital of Hunan University of Medicine
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. For women:

    • 20 to 40 years of age.
    • Diagnosed with gestational diabetes mellitus during the most recent pregnancy.
    • Have basic literacy and sufficient cognitive and physical ability to participate in the study.
    • Living with their spouse.
    • Able to use a smartphone.
    • Willing to participate in the study.
  2. For spouses:

    • Living with an eligible woman with a history of gestational diabetes mellitus.
    • Have basic literacy and sufficient cognitive and physical ability to participate in the study.
    • Able to use a smartphone.
    • Willing to participate in the study.

Exclusion Criteria:

  1. For women:

    • Diabetes diagnosed before pregnancy or after delivery.
    • Pregnant at the time of screening.
    • Currently using medications that affect glucose metabolism or medications for weight loss.
    • Cognitive impairment or a serious psychiatric disorder.
    • A contraindication to postpartum exercise.
    • Current participation in another lifestyle intervention program.
  2. For spouses:

    • A diagnosed major chronic disease, such as coronary heart disease or diabetes, or another serious physical illness.
    • Cognitive impairment or a serious psychiatric disorder.
    • Current participation in another lifestyle intervention program.

Women with a history of gestational diabetes mellitus and their spouses will be recruited during postpartum follow-up visits at the participating hospitals. Both members of the couple must meet their respective eligibility criteria.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Couple-based Collaborative Lifestyle Intervention arm
Women with a history of gestational diabetes and their spouses will receive a 3-month couple-based lifestyle intervention consisting of health modules delivered through health education posts, instant messages, and short videos.
Couples will receive a 3-month lifestyle intervention delivered through health education posts, short videos, and instant messages. The intervention addresses healthy diet, physical activity, and stress management, with smoking cessation and alcohol reduction provided when applicable. Couple-specific components focus on role allocation, couple communication, and time management.
Active Comparator: Woman-only Lifestyle Intervention arm
Women with a history of gestational diabetes will receive a 3-month lifestyle intervention delivered through health education posts, without the couple collaboration and support components (instant messages, and short videos).
Women will receive a 3-month lifestyle intervention delivered through health education posts focusing on healthy diet, physical activity, and stress management, with smoking cessation and alcohol reduction provided when applicable. The intervention does not include the couple collaboration and support components provided in the experimental group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
2 h Oral Glucose Tolerance Test
Time Frame: Baseline and 6 months
Two-hour plasma glucose will be measured 2 hours after a 75-g oral glucose load during an oral glucose tolerance test and reported in mmol/L.
Baseline and 6 months
Body Mass Index
Time Frame: Baseline, 3 months, and 6 months
Body mass index will be calculated as weight in kilograms divided by height in meters squared (kg/m²).
Baseline, 3 months, and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fasting Blood Glucose
Time Frame: Baseline and 6 months
Fasting blood glucose will be measured from venous blood samples after an overnight fast and expressed in mmol/L.
Baseline and 6 months
Total Cholesterol
Time Frame: Baseline and 6 months
Total cholesterol will be measured from venous blood samples after an overnight fast and expressed in mmol/L.
Baseline and 6 months
Triglycerides
Time Frame: Baseline and 6 months
Triglycerides will be measured from venous blood samples after an overnight fast and expressed in mmol/L.
Baseline and 6 months
High-Density Lipoprotein Cholesterol
Time Frame: Baseline and 6 months
High-density lipoprotein cholesterol will be measured from venous blood samples after an overnight fast and expressed in mmol/L.
Baseline and 6 months
Low-Density Lipoprotein Cholesterol
Time Frame: Baseline and 6 months
Low-density lipoprotein cholesterol will be measured from venous blood samples after an overnight fast and expressed in mmol/L.
Baseline and 6 months
Waist Circumference
Time Frame: Baseline, 3 months, and 6 months
Waist circumference will be measured with the participant standing, using a non-stretchable measuring tape positioned horizontally one fingerbreadth above the umbilicus, and recorded in centimeters.
Baseline, 3 months, and 6 months
Composite Z Score for Healthy Lifestyle Behavior
Time Frame: Baseline, 3 months, and 6 months
A composite healthy lifestyle behavior score will be calculated by standardizing behavior measures into Z scores.
Baseline, 3 months, and 6 months
Diabetes Risk-Related Eating Behavior
Time Frame: Baseline, 3 months, and 6 months
Diabetes risk-related eating behaviors will be assessed using the Diabetes Risk-Related Eating Behavior Scale.
Baseline, 3 months, and 6 months
Physical Activity
Time Frame: Baseline, 3 months, and 6 months
Physical activity will be assessed using the International Physical Activity Questionnaire-Short Form.
Baseline, 3 months, and 6 months
Depression
Time Frame: Baseline, 3 months, and 6 months
Depressive symptoms will be assessed using the 9-item Patient Health Questionnaire.
Baseline, 3 months, and 6 months
Perceived Stress
Time Frame: Baseline, 3 months, and 6 months
Perceived stress will be assessed using the Perceived Stress Scale.
Baseline, 3 months, and 6 months
Dietary Self-Efficacy
Time Frame: Baseline, 3 months, and 6 months
Confidence in adopting and maintaining healthy dietary behaviors will be assessed using the Dietary Self-Efficacy Scale.
Baseline, 3 months, and 6 months
Exercise Self-Efficacy
Time Frame: Baseline, 3 months, and 6 months
Confidence in engaging in and maintaining physical activity will be assessed using the Exercise Self-Efficacy Scale.
Baseline, 3 months, and 6 months
Couple Relationship Quality
Time Frame: Baseline, 3 months, and 6 months
Couple Relationship Quality will be assessed using the Marital Satisfaction Subscale.
Baseline, 3 months, and 6 months
Dyadic Coping Ability
Time Frame: Baseline, 3 months, and 6 months
Dyadic Coping Ability will be assessed using the Dyadic Coping Scale.
Baseline, 3 months, and 6 months
Life Satisfaction
Time Frame: Baseline, 3 months, and 6 months
Overall life satisfaction will be assessed using the Satisfaction With Life Scale.
Baseline, 3 months, and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Chunxia Cheng, The Third Xiangya Hospital of Central South University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 15, 2026

Primary Completion (Estimated)

August 30, 2028

Study Completion (Estimated)

August 30, 2028

Study Registration Dates

First Submitted

August 8, 2026

First Submitted That Met QC Criteria

August 8, 2026

First Posted (Actual)

August 13, 2026

Study Record Updates

Last Update Posted (Actual)

August 13, 2026

Last Update Submitted That Met QC Criteria

August 8, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2025JK2117

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe